Novel Insights into Leukemogenesis
Description of the granted funding
We have very recently identified the first predisposing gene for a specific type of acute myeloid leukemia (AML). We have demonstrated that a homozygous mutation in ERCC6L2 gene causes AML with distinct characteristics. We have shown that individuals with the bi-allelic mutations develope AML with erythroid predominance and very poor prognosis. Hence, ERCC6L2 defines a novel entity within inherited acute myeloid leukemia. We will provide new insights into leukemogenesis and normal hematopoiesis focusing on the specific features of ERCC6L2 defect-driven leukemia. Furthermore, we will gain deeper understanding in normal hematopoiesis.
Show moreStarting year
2022
End year
2026
Granted funding
Funder
Research Council of Finland
Funding instrument
Academy projects
Other information
Funding decision number
349760
Fields of science
Genetics, developmental biology, physiology
Research fields
Perinnöllisyystiede
Identified topics
cancer